Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

March 31, 2008

Study Completion Date

February 28, 2009

Conditions
Prostate Cancer
Interventions
DRUG

risedronate

35 mg/week by mouth

DRUG

Placebo risedronate oral tablet

One tablet by mouth every week as directed

Trial Locations (1)

06030

University of Connecticut Health Center, Farmington

All Listed Sponsors
collaborator

Proctor and Gamble/Aventis

UNKNOWN

lead

UConn Health

OTHER

NCT00859027 - Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer | Biotech Hunter | Biotech Hunter